Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
CHINA PHARMA HOLDINGS, INC. issued 12,600,000 restricted shares of common stock of common stock to Xiaoyun Chen for $8.82 million.
- Security
- common stock
- Shares
- 12,600,000 restricted shares of common stock
- Purchaser
- Xiaoyun Chen
- Consideration
- $8.82 million
Exact text from the filing
research and development, writing of registration materials, registration application and other technical services. The transfer price as contemplated by the Agreement is $8.82 million, which will be paid in the form of common stock of the Company, par value $0.001 per share, at $0.70 per share. The closing is expected to be completed by February 20, 2026.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
CHINA PHARMA HOLDINGS, INC. entered into Technology Transfer Agreement with Xiaoyun Chen valued at $8.82 million in common stock at $0.70 per share (effective 2026-02-05).
- Action
- entry
- Agreement
- license
- Counterparty
- Xiaoyun Chen
- Value
- $8.82 million in common stock at $0.70 per share
- Effective
- 2026-02-05
Exact text from the filing
On February 5, 2026 (the "Signing Date"), Hainan Helpson Medical & Biotechnology Co., Ltd (" Helpson "), a wholly owned subsidiary of China Pharma Holdings, Inc. (the " Company "), entered into a Technology Transfer Agreement (the " Agreement ") with Xiaoyun Chen (the " Transferor ").
View on SEC.gov